Drug Type CAR-NK, Induced pluripotent stem cells (iPSC) |
Synonyms- |
Target |
Action modulators |
Mechanism CCL19 modulators(C-C motif chemokine ligand 19 modulators), IL-7 modulators(interleukin 7 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | South Korea | 05 Nov 2024 |